Skip to main navigation
Investors
Contact
Global Operations

North America

  • Canada
  • Mexico
  • USA

South America

  • Argentina
  • Brazil

Asia

  • China
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan

Middle East

  • United Arab Emirates

Africa

  • South Africa

Australia

  • Australia New Zealand

Europe

  • Austria
  • Belgium Luxembourg
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
Gilead Logo
  • Our Purpose
    Mission and Core Values Partnerships and Community Advancing Global Health Giving Medication Access
  • About
    Leadership Ethics and Code of Conduct U.S. Locations
  • Science & Medicine
    Medicines Pipeline Research
  • News and Press
    Press Room Company Statements Events Annual Report
  • Careers
    Now Hiring Culture Diversity & Inclusion Benefits Internships
  • Utility
    Privacy Statements Terms Of Use Social Media Guidelines EU Data Disclosure Sitemap
BACK TO MAIN MENU Partnerships and Community COMPASS Initiative Gilead Lift Gilead HIV Age Positively
BACK TO MAIN MENU Advancing Global Health HCV Elimination Ebola
BACK TO MAIN MENU Giving Grant Recipients Grant Funding Gilead Foundation Gilead Public Health Award
BACK TO MAIN MENU Medication Access U.S. Patient Access Disaster Product Replacement Global Access
BACK TO MAIN MENU Ethics and Code of Conduct Policies Global Transparency Anti-Counterfeiting Consumer Product Safety Supplier Info Authorized Distributors
BACK TO MAIN MENU Research Compassionate Use Investigator Sponsored Research Clinical Trials HIV/HCV No Co-Infection (NoCo) 2018 Program
BACK TO MAIN MENU Press Room Press Releases Press FAQS
BACK TO MAIN MENU Company Statements Discount For Ambisome Gilead 2017 Year in Review 100 Corporate Equality Score Emergency Disaster Response Gilead Year in Review 2016 Top Corporate Philanthropist HIV Medicines Reach 10 Million People Discover Study Of FTAF For PrEP Corporate Responsibility Report 2015 Gilead Supports PrEP Education Corporate Contributions Report Celebrating Transgender Awareness Week Kite Pharma Harnessing The Immune System Grants for SCLAN Authorized Generics For HCV
BACK TO MAIN MENU Annual Report 2017 Year in Review
BACK TO MAIN MENU Privacy Statements Cookie Statement Website Privacy Statement
BACK TO MAIN MENU Social Media Guidelines Linkedin Guidelines Twitter Guidelines
BACK TO MAIN MENU

North America

  • Canada
  • Mexico
  • USA

South America

  • Argentina
  • Brazil

Asia

  • China
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan

Middle East

  • United Arab Emirates

Africa

  • South Africa

Australia

  • Australia New Zealand

Europe

  • Austria
  • Belgium Luxembourg
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland & The Baltics
  • Portugal
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
BACK TO MAIN MENU

Contact

  • Request Medication Information
  • Information for Suppliers
  • Partnership Request
  • Investors
  • Contact
  • Global Operations
Toggle Inner Dropdown
BACK TO MAIN MENU Google.com
INVESTOR MENU
  • Investor Overview
  • Investor Fact Sheet
  • Press Releases
  • Corporate Governance
    • Documents and Charters
    • Leadership
    • Committee Composition
    • Code of Ethics
    • Anti-Bribery and Anti-Corruption Policy
  • Stock Information
    • Stock Quote and Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial & Filings
    • Quarterly Earnings
    • SEC Filings
    • GAAP to Non-GAAP Reconciliation
    • Annual Reports
    • Annual Meeting Materials
  • Events & Presentations
    • Events
    • Presentations
  • Investor Resources
    • FAQs
    • Investor Contact
    • Investor Disclaimer
    • Email Alerts

Events

Events

Upcoming Events

  • Feb 4, 2021 at 4:30 PM EST

    Fourth Quarter 2020 Gilead Sciences Earnings Conference Call

Past Events

  • Jan 13, 2020 at 9:30 AM PST

    Gilead Sciences at the 38th Annual J.P. Morgan Healthcare Conference
  • Oct 24, 2019 at 4:30 PM EDT

    Third Quarter 2019 Gilead Sciences Earnings Conference Call
  • Sep 10, 2019 at 10:00 AM EDT

    Gilead Sciences at the Morgan Stanley Global Healthcare Conference
  • Jul 30, 2019 at 4:30 PM EDT

    Second Quarter 2019 Gilead Sciences Earnings Conference Call
  • Jul 14, 2019 at 3:00 PM EDT

    Gilead Sciences and Galapagos Global Collaboration Conference Call
  • Jun 5, 2019 at 11:30 AM EDT

    Gilead Sciences at the Jefferies 2019 Healthcare Conference
  • May 14, 2019 at 10:00 AM PDT

    Gilead Sciences at the Bank of America Merrill Lynch 2019 Health Care Conference
  • May 8, 2019 at 10:00 AM PDT

    Gilead Sciences 2019 Stockholders Meeting
  • May 2, 2019 at 4:30 PM EDT

    First Quarter 2019 Gilead Sciences Earnings Conference Call
  • Mar 12, 2019 at 10:45 AM EDT

    Gilead Sciences at the Barclays Global Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

© 2018 Gilead. All rights reserved.

AREAS OF INTEREST

Site - Areas of Interest

  • Partnerships and Community
  • Pipeline
  • Medicines
  • Job Search

INFORMATION

Site - Information

  • Contact Us
  • Press Room
  • Investor Calls
  • Sitemap

LEGAL

Site - Legal

  • Privacy Policy
  • Terms of Use
  • EU Data Disclosure
  • Social Media Guidlines

FOLLOW US

  • facebook
  • linkedin
  • twitter
  • youtube

Headline

Intersititial body copy

Ok Cancel